Protein kinase C-δ signaling regulates glucagon secretion from pancreatic islets
Autor: | Natsumi Tokashiki, Motoyuki Tamaki, Kiyotake Yamamoto, Hiroyuki Mizuguchi, Youichi Sato, Hiroyuki Fukui, Aiko Yamauchi, Makoto Kobayashi |
---|---|
Rok vydání: | 2017 |
Předmět: |
0301 basic medicine
Male medicine.medical_specialty endocrine system 030209 endocrinology & metabolism In Vitro Techniques Glucagon General Biochemistry Genetics and Molecular Biology Diabetes Mellitus Experimental 03 medical and health sciences chemistry.chemical_compound Islets of Langerhans Mice 0302 clinical medicine Internal medicine medicine Animals Humans Phosphorylation Protein kinase C streptozotocin-induced diabetic mice PKCδ Pancreatic islets pancreatic α-cells Glucagon secretion General Medicine Mice Inbred C57BL Protein Kinase C-delta 030104 developmental biology Endocrinology medicine.anatomical_structure chemistry Phorbol Disease Progression glucagon secretion Tetradecanoylphorbol Acetate Quercetin Signal transduction Rottlerin hormones hormone substitutes and hormone antagonists Signal Transduction |
Zdroj: | The journal of medical investigation : JMI. 64(1.2) |
ISSN: | 1349-6867 |
Popis: | Accumulating evidence supports the "glucagonocentric hypothesis", in which antecedent α-cell failure and inhibition of glucagon secretion are responsible for diabetes progression. Protein kinase C (PKC) is involved in glucagon secretion from α-cells, although which PKC isozyme is involved and the mechanism underlying this PKC-regulated glucagon secretion remains unknown. Here, the involvement of PKCδ in the onset and progression of diabetes was elucidated. Immunofluorescence studies revealed that PKCδ was expressed and activated in α-cells of STZ-induced diabetic model mice. Phorbol 12-myristate 13-acetate (PMA) stimulation significantly augmented glucagon secretion from isolated islets. Pre-treatment with quercetin and rottlerin, PKCδ signaling inhibitors, significantly suppressed the PMA-induced elevation of glucagon secretion. While Go6976, a Ca2+-dependent PKC selective inhibitor did not suppress glucagon secretion. Quercetin suppressed PMA-induced phosphorylation of Tyr311 of PKCδ in isolated islets. However, quercetin itself had no effect on either glucagon secretion or glucagon mRNA expression. Our data suggest that PKCδ signaling inhibitors suppressed glucagon secretion. Elucidation of detailed signaling pathways causing PKCδ activation in the onset and progression of diabetes followed by the augmentation of glucagon secretion could lead to the identification of novel therapeutic target molecules and the development of novel therapeutic drugs for diabetes. J. Med. Invest. 64: 122-128, February, 2017. |
Databáze: | OpenAIRE |
Externí odkaz: |